Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-16

FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for butorphanol tartrate by Hikma Pharmaceuticals USA Inc. (ANDA 078400). This action confirms continued regulatory appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butorphanol Tartrate (Butorphanol tartrate)

Snippet

SUPPL AP for BUTORPHANOL TARTRATE (BUTORPHANOL TARTRATE)